Marshall Wace’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-574,150
| Closed | -$901K | – | 2631 |
|
|
2024
Q3 | $901K | Sell |
574,150
-616,298
| -52% | -$968K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $2M | Buy |
1,190,448
+691,276
| +138% | +$1.16M | ﹤0.01% | 1245 |
|
|
2024
Q1 | $1.2M | Buy |
+499,172
| New | +$1.2M | ﹤0.01% | 1379 |
|
|
2023
Q3 | – | Sell |
-125,287
| Closed | -$287K | – | 2129 |
|
|
2023
Q2 | $287K | Buy |
+125,287
| New | +$287K | ﹤0.01% | 1735 |
|
|
2020
Q4 | – | Sell |
-281,647
| Closed | -$406K | – | 1920 |
|
|
2020
Q3 | $406K | Sell |
281,647
-654,944
| -70% | -$944K | ﹤0.01% | 1251 |
|
|
2020
Q2 | $1.87M | Sell |
936,591
-409,019
| -30% | -$818K | 0.01% | 793 |
|
|
2020
Q1 | $2.62M | Buy |
1,345,610
+494,682
| +58% | +$965K | 0.03% | 534 |
|
|
2019
Q4 | $3.53M | Buy |
+850,928
| New | +$3.53M | 0.02% | 609 |
|
|
2019
Q1 | – | Sell |
-264,139
| Closed | -$1.75M | – | 1904 |
|
|
2018
Q4 | $1.75M | Buy |
264,139
+229,876
| +671% | +$1.53M | 0.02% | 758 |
|
|
2018
Q3 | $366K | Sell |
34,263
-616,555
| -95% | -$6.59M | ﹤0.01% | 988 |
|
|
2018
Q2 | $7.81M | Sell |
650,818
-85,727
| -12% | -$1.03M | 0.12% | 210 |
|
|
2018
Q1 | $6.31M | Buy |
+736,545
| New | +$6.31M | 0.26% | 92 |
|
|
2015
Q3 | – | Sell |
-12,945
| Closed | -$104K | – | 1007 |
|
|
2015
Q2 | $104K | Sell |
12,945
-523,741
| -98% | -$4.21M | ﹤0.01% | 855 |
|
|
2015
Q1 | $507K | Buy |
+536,686
| New | +$507K | 0.01% | 668 |
|